The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Identifieur interne : 001644 ( Main/Exploration ); précédent : 001643; suivant : 001645The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Auteurs : Gerwyn Morris [Royaume-Uni] ; Ken Walder [Australie] ; Basant K. Puri [Royaume-Uni] ; Michael Berk [Australie] ; Michael Maes [Australie, Thaïlande, Brésil]Source :
- Molecular neurobiology [ 1559-1182 ] ; 2016.
Descripteurs français
- KwdFr :
- Acides gras omega-3 (administration et posologie), Animaux (MeSH), Humains (MeSH), Lipoylation (effets des médicaments et des substances chimiques), Lipoylation (physiologie), Maladies du système nerveux (immunologie), Maladies du système nerveux (métabolisme), Maladies du système nerveux (traitement médicamenteux), Membrane cellulaire (effets des médicaments et des substances chimiques), Membrane cellulaire (immunologie), Membrane cellulaire (métabolisme), Microdomaines membranaires (effets des médicaments et des substances chimiques), Microdomaines membranaires (immunologie), Microdomaines membranaires (métabolisme), Neuro-immunomodulation (effets des médicaments et des substances chimiques), Neuro-immunomodulation (physiologie), Oxydoréduction (MeSH), Stress nitrosatif (effets des médicaments et des substances chimiques), Stress nitrosatif (physiologie), Stress oxydatif (effets des médicaments et des substances chimiques), Stress oxydatif (physiologie), Systèmes de délivrance de médicaments (tendances), Transduction du signal (effets des médicaments et des substances chimiques), Transduction du signal (physiologie).
- MESH :
- administration et posologie : Acides gras omega-3.
- effets des médicaments et des substances chimiques : Lipoylation, Membrane cellulaire, Microdomaines membranaires, Neuro-immunomodulation, Stress nitrosatif, Stress oxydatif, Transduction du signal.
- immunologie : Maladies du système nerveux, Membrane cellulaire, Microdomaines membranaires.
- métabolisme : Maladies du système nerveux, Membrane cellulaire, Microdomaines membranaires.
- physiologie : Lipoylation, Neuro-immunomodulation, Stress nitrosatif, Stress oxydatif, Transduction du signal.
- tendances : Systèmes de délivrance de médicaments.
- traitement médicamenteux : Maladies du système nerveux.
- Animaux, Humains, Oxydoréduction.
English descriptors
- KwdEn :
- Animals (MeSH), Cell Membrane (drug effects), Cell Membrane (immunology), Cell Membrane (metabolism), Drug Delivery Systems (trends), Fatty Acids, Omega-3 (administration & dosage), Humans (MeSH), Lipoylation (drug effects), Lipoylation (physiology), Membrane Microdomains (drug effects), Membrane Microdomains (immunology), Membrane Microdomains (metabolism), Nervous System Diseases (drug therapy), Nervous System Diseases (immunology), Nervous System Diseases (metabolism), Neuroimmunomodulation (drug effects), Neuroimmunomodulation (physiology), Nitrosative Stress (drug effects), Nitrosative Stress (physiology), Oxidation-Reduction (MeSH), Oxidative Stress (drug effects), Oxidative Stress (physiology), Signal Transduction (drug effects), Signal Transduction (physiology).
- MESH :
- chemical , administration & dosage : Fatty Acids, Omega-3.
- drug effects : Cell Membrane, Lipoylation, Membrane Microdomains, Neuroimmunomodulation, Nitrosative Stress, Oxidative Stress, Signal Transduction.
- drug therapy : Nervous System Diseases.
- immunology : Cell Membrane, Membrane Microdomains, Nervous System Diseases.
- metabolism : Cell Membrane, Membrane Microdomains, Nervous System Diseases.
- physiology : Lipoylation, Neuroimmunomodulation, Nitrosative Stress, Oxidative Stress, Signal Transduction.
- trends : Drug Delivery Systems.
- Animals, Humans, Oxidation-Reduction.
Abstract
Oxidative and nitrosative stress (O&NS) is causatively implicated in the pathogenesis of Alzheimer's and Parkinson's disease, multiple sclerosis, chronic fatigue syndrome, schizophrenia and depression. Many of the consequences stemming from O&NS, including damage to proteins, lipids and DNA, are well known, whereas the effects of O&NS on lipoprotein-based cellular signalling involving palmitoylation and plasma membrane lipid rafts are less well documented. The aim of this narrative review is to discuss the mechanisms involved in lipid-based signalling, including palmitoylation, membrane/lipid raft (MLR) and n-3 polyunsaturated fatty acid (PUFA) functions, the effects of O&NS processes on these processes and their role in the abovementioned diseases. S-palmitoylation is a post-translational modification, which regulates protein trafficking and association with the plasma membrane, protein subcellular location and functions. Palmitoylation and MRLs play a key role in neuronal functions, including glutamatergic neurotransmission, and immune-inflammatory responses. Palmitoylation, MLRs and n-3 PUFAs are vulnerable to the corruptive effects of O&NS. Chronic O&NS inhibits palmitoylation and causes profound changes in lipid membrane composition, e.g. n-3 PUFA depletion, increased membrane permeability and reduced fluidity, which together lead to disorders in intracellular signal transduction, receptor dysfunction and increased neurotoxicity. Disruption of lipid-based signalling is a source of the neuroimmune disorders involved in the pathophysiology of the abovementioned diseases. n-3 PUFA supplementation is a rational therapeutic approach targeting disruptions in lipid-based signalling.
DOI: 10.1007/s12035-015-9392-y
PubMed: 26310971
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.</title>
<author><name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
<affiliation wicri:level="1"><nlm:affiliation>Tir Na Nog, Bryn Road seaside 87, Llanelli, SA152LW, Wales, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Tir Na Nog, Bryn Road seaside 87, Llanelli, SA152LW, Wales</wicri:regionArea>
<wicri:noRegion>Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Walder, Ken" sort="Walder, Ken" uniqKey="Walder K" first="Ken" last="Walder">Ken Walder</name>
<affiliation wicri:level="1"><nlm:affiliation>Metabolic Research Unit, Deakin University, Geelong, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolic Research Unit, Deakin University, Geelong</wicri:regionArea>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Puri, Basant K" sort="Puri, Basant K" uniqKey="Puri B" first="Basant K" last="Puri">Basant K. Puri</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Hammersmith Hospital, Imperial College London, London, W12 0HS, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Medicine, Hammersmith Hospital, Imperial College London, London, W12 0HS</wicri:regionArea>
<wicri:noRegion>W12 0HS</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<affiliation wicri:level="1"><nlm:affiliation>Orygen, The National Centre of Excellence in Youth Mental Health and the Centre of Youth Mental Health, Poplar Road 35, Parkville, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Orygen, The National Centre of Excellence in Youth Mental Health and the Centre of Youth Mental Health, Poplar Road 35, Parkville, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Royal Parade 30, Parkville, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Royal Parade 30, Parkville, 3052</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Level 1 North, Main Block, Parkville, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Level 1 North, Main Block, Parkville, 3052</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220</wicri:regionArea>
<wicri:noRegion>3220</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
<affiliation wicri:level="1"><nlm:affiliation>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220, Australia. dr.michaelmaes@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220</wicri:regionArea>
<wicri:noRegion>3220</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.michaelmaes@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, Brazil. dr.michaelmaes@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina</wicri:regionArea>
<wicri:noRegion>Londrina</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26310971</idno>
<idno type="pmid">26310971</idno>
<idno type="doi">10.1007/s12035-015-9392-y</idno>
<idno type="wicri:Area/Main/Corpus">001B48</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001B48</idno>
<idno type="wicri:Area/Main/Curation">001B48</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001B48</idno>
<idno type="wicri:Area/Main/Exploration">001B48</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.</title>
<author><name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
<affiliation wicri:level="1"><nlm:affiliation>Tir Na Nog, Bryn Road seaside 87, Llanelli, SA152LW, Wales, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Tir Na Nog, Bryn Road seaside 87, Llanelli, SA152LW, Wales</wicri:regionArea>
<wicri:noRegion>Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Walder, Ken" sort="Walder, Ken" uniqKey="Walder K" first="Ken" last="Walder">Ken Walder</name>
<affiliation wicri:level="1"><nlm:affiliation>Metabolic Research Unit, Deakin University, Geelong, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolic Research Unit, Deakin University, Geelong</wicri:regionArea>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Puri, Basant K" sort="Puri, Basant K" uniqKey="Puri B" first="Basant K" last="Puri">Basant K. Puri</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Hammersmith Hospital, Imperial College London, London, W12 0HS, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Medicine, Hammersmith Hospital, Imperial College London, London, W12 0HS</wicri:regionArea>
<wicri:noRegion>W12 0HS</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<affiliation wicri:level="1"><nlm:affiliation>Orygen, The National Centre of Excellence in Youth Mental Health and the Centre of Youth Mental Health, Poplar Road 35, Parkville, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Orygen, The National Centre of Excellence in Youth Mental Health and the Centre of Youth Mental Health, Poplar Road 35, Parkville, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Royal Parade 30, Parkville, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Royal Parade 30, Parkville, 3052</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Level 1 North, Main Block, Parkville, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Level 1 North, Main Block, Parkville, 3052</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220</wicri:regionArea>
<wicri:noRegion>3220</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
<affiliation wicri:level="1"><nlm:affiliation>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220, Australia. dr.michaelmaes@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220</wicri:regionArea>
<wicri:noRegion>3220</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.michaelmaes@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, Brazil. dr.michaelmaes@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina</wicri:regionArea>
<wicri:noRegion>Londrina</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Molecular neurobiology</title>
<idno type="eISSN">1559-1182</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term>
<term>Cell Membrane (drug effects)</term>
<term>Cell Membrane (immunology)</term>
<term>Cell Membrane (metabolism)</term>
<term>Drug Delivery Systems (trends)</term>
<term>Fatty Acids, Omega-3 (administration & dosage)</term>
<term>Humans (MeSH)</term>
<term>Lipoylation (drug effects)</term>
<term>Lipoylation (physiology)</term>
<term>Membrane Microdomains (drug effects)</term>
<term>Membrane Microdomains (immunology)</term>
<term>Membrane Microdomains (metabolism)</term>
<term>Nervous System Diseases (drug therapy)</term>
<term>Nervous System Diseases (immunology)</term>
<term>Nervous System Diseases (metabolism)</term>
<term>Neuroimmunomodulation (drug effects)</term>
<term>Neuroimmunomodulation (physiology)</term>
<term>Nitrosative Stress (drug effects)</term>
<term>Nitrosative Stress (physiology)</term>
<term>Oxidation-Reduction (MeSH)</term>
<term>Oxidative Stress (drug effects)</term>
<term>Oxidative Stress (physiology)</term>
<term>Signal Transduction (drug effects)</term>
<term>Signal Transduction (physiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acides gras omega-3 (administration et posologie)</term>
<term>Animaux (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Lipoylation (effets des médicaments et des substances chimiques)</term>
<term>Lipoylation (physiologie)</term>
<term>Maladies du système nerveux (immunologie)</term>
<term>Maladies du système nerveux (métabolisme)</term>
<term>Maladies du système nerveux (traitement médicamenteux)</term>
<term>Membrane cellulaire (effets des médicaments et des substances chimiques)</term>
<term>Membrane cellulaire (immunologie)</term>
<term>Membrane cellulaire (métabolisme)</term>
<term>Microdomaines membranaires (effets des médicaments et des substances chimiques)</term>
<term>Microdomaines membranaires (immunologie)</term>
<term>Microdomaines membranaires (métabolisme)</term>
<term>Neuro-immunomodulation (effets des médicaments et des substances chimiques)</term>
<term>Neuro-immunomodulation (physiologie)</term>
<term>Oxydoréduction (MeSH)</term>
<term>Stress nitrosatif (effets des médicaments et des substances chimiques)</term>
<term>Stress nitrosatif (physiologie)</term>
<term>Stress oxydatif (effets des médicaments et des substances chimiques)</term>
<term>Stress oxydatif (physiologie)</term>
<term>Systèmes de délivrance de médicaments (tendances)</term>
<term>Transduction du signal (effets des médicaments et des substances chimiques)</term>
<term>Transduction du signal (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Fatty Acids, Omega-3</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acides gras omega-3</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cell Membrane</term>
<term>Lipoylation</term>
<term>Membrane Microdomains</term>
<term>Neuroimmunomodulation</term>
<term>Nitrosative Stress</term>
<term>Oxidative Stress</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Lipoylation</term>
<term>Membrane cellulaire</term>
<term>Microdomaines membranaires</term>
<term>Neuro-immunomodulation</term>
<term>Stress nitrosatif</term>
<term>Stress oxydatif</term>
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Maladies du système nerveux</term>
<term>Membrane cellulaire</term>
<term>Microdomaines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Cell Membrane</term>
<term>Membrane Microdomains</term>
<term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Cell Membrane</term>
<term>Membrane Microdomains</term>
<term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Maladies du système nerveux</term>
<term>Membrane cellulaire</term>
<term>Microdomaines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Lipoylation</term>
<term>Neuro-immunomodulation</term>
<term>Stress nitrosatif</term>
<term>Stress oxydatif</term>
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lipoylation</term>
<term>Neuroimmunomodulation</term>
<term>Nitrosative Stress</term>
<term>Oxidative Stress</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Systèmes de délivrance de médicaments</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies du système nerveux</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Drug Delivery Systems</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
<term>Oxidation-Reduction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Humains</term>
<term>Oxydoréduction</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Oxidative and nitrosative stress (O&NS) is causatively implicated in the pathogenesis of Alzheimer's and Parkinson's disease, multiple sclerosis, chronic fatigue syndrome, schizophrenia and depression. Many of the consequences stemming from O&NS, including damage to proteins, lipids and DNA, are well known, whereas the effects of O&NS on lipoprotein-based cellular signalling involving palmitoylation and plasma membrane lipid rafts are less well documented. The aim of this narrative review is to discuss the mechanisms involved in lipid-based signalling, including palmitoylation, membrane/lipid raft (MLR) and n-3 polyunsaturated fatty acid (PUFA) functions, the effects of O&NS processes on these processes and their role in the abovementioned diseases. S-palmitoylation is a post-translational modification, which regulates protein trafficking and association with the plasma membrane, protein subcellular location and functions. Palmitoylation and MRLs play a key role in neuronal functions, including glutamatergic neurotransmission, and immune-inflammatory responses. Palmitoylation, MLRs and n-3 PUFAs are vulnerable to the corruptive effects of O&NS. Chronic O&NS inhibits palmitoylation and causes profound changes in lipid membrane composition, e.g. n-3 PUFA depletion, increased membrane permeability and reduced fluidity, which together lead to disorders in intracellular signal transduction, receptor dysfunction and increased neurotoxicity. Disruption of lipid-based signalling is a source of the neuroimmune disorders involved in the pathophysiology of the abovementioned diseases. n-3 PUFA supplementation is a rational therapeutic approach targeting disruptions in lipid-based signalling.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26310971</PMID>
<DateCompleted><Year>2018</Year>
<Month>01</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>53</Volume>
<Issue>7</Issue>
<PubDate><Year>2016</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>Molecular neurobiology</Title>
<ISOAbbreviation>Mol Neurobiol</ISOAbbreviation>
</Journal>
<ArticleTitle>The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.</ArticleTitle>
<Pagination><MedlinePgn>4638-58</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-015-9392-y</ELocationID>
<Abstract><AbstractText>Oxidative and nitrosative stress (O&NS) is causatively implicated in the pathogenesis of Alzheimer's and Parkinson's disease, multiple sclerosis, chronic fatigue syndrome, schizophrenia and depression. Many of the consequences stemming from O&NS, including damage to proteins, lipids and DNA, are well known, whereas the effects of O&NS on lipoprotein-based cellular signalling involving palmitoylation and plasma membrane lipid rafts are less well documented. The aim of this narrative review is to discuss the mechanisms involved in lipid-based signalling, including palmitoylation, membrane/lipid raft (MLR) and n-3 polyunsaturated fatty acid (PUFA) functions, the effects of O&NS processes on these processes and their role in the abovementioned diseases. S-palmitoylation is a post-translational modification, which regulates protein trafficking and association with the plasma membrane, protein subcellular location and functions. Palmitoylation and MRLs play a key role in neuronal functions, including glutamatergic neurotransmission, and immune-inflammatory responses. Palmitoylation, MLRs and n-3 PUFAs are vulnerable to the corruptive effects of O&NS. Chronic O&NS inhibits palmitoylation and causes profound changes in lipid membrane composition, e.g. n-3 PUFA depletion, increased membrane permeability and reduced fluidity, which together lead to disorders in intracellular signal transduction, receptor dysfunction and increased neurotoxicity. Disruption of lipid-based signalling is a source of the neuroimmune disorders involved in the pathophysiology of the abovementioned diseases. n-3 PUFA supplementation is a rational therapeutic approach targeting disruptions in lipid-based signalling.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morris</LastName>
<ForeName>Gerwyn</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Tir Na Nog, Bryn Road seaside 87, Llanelli, SA152LW, Wales, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Walder</LastName>
<ForeName>Ken</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Metabolic Research Unit, Deakin University, Geelong, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Puri</LastName>
<ForeName>Basant K</ForeName>
<Initials>BK</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Hammersmith Hospital, Imperial College London, London, W12 0HS, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berk</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Orygen, The National Centre of Excellence in Youth Mental Health and the Centre of Youth Mental Health, Poplar Road 35, Parkville, 3052, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Royal Parade 30, Parkville, 3052, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Level 1 North, Main Block, Parkville, 3052, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Maes</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>IMPACT Strategic Research Center, School of Medicine, Deakin University, P.O. Box 291, Geelong, 3220, Australia. dr.michaelmaes@hotmail.com.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.michaelmaes@hotmail.com.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, Brazil. dr.michaelmaes@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>08</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mol Neurobiol</MedlineTA>
<NlmUniqueID>8900963</NlmUniqueID>
<ISSNLinking>0893-7648</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016503" MajorTopicYN="Y">Drug Delivery Systems</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015525" MajorTopicYN="N">Fatty Acids, Omega-3</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054878" MajorTopicYN="N">Lipoylation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021962" MajorTopicYN="N">Membrane Microdomains</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015213" MajorTopicYN="N">Neuroimmunomodulation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073039" MajorTopicYN="N">Nitrosative Stress</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Chronic fatigue</Keyword>
<Keyword MajorTopicYN="Y">Cytokines</Keyword>
<Keyword MajorTopicYN="Y">Depression</Keyword>
<Keyword MajorTopicYN="Y">Inflammation</Keyword>
<Keyword MajorTopicYN="Y">Metabolism</Keyword>
<Keyword MajorTopicYN="Y">Oxidative and nitrosative stress</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>06</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>08</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>1</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26310971</ArticleId>
<ArticleId IdType="doi">10.1007/s12035-015-9392-y</ArticleId>
<ArticleId IdType="pii">10.1007/s12035-015-9392-y</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Cell Sci. 2005 Jun 1;118(Pt 11):2415-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15923654</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4888-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16547139</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Neurobiol. 2013 Mar;22(1):11-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23585717</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Apr 21;9(4):e95021</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24751652</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Life Sci. 2013 Dec;70(23):4411-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23475111</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Metab Brain Dis. 2012 Dec;27(4):415-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22614823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Isr J Psychiatry Relat Sci. 2008;45(1):19-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18587166</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Rev Neurobiol. 2004;59:297-326</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15006493</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr Biochem. 2012 Feb;23(2):101-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22137258</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19902-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17179037</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2005 Dec;6(12):1191-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16369558</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2014 Jan 17;443(3):991-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24361890</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Med. 2013 Jul;32(1):108-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23615851</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antioxid Redox Signal. 2007 Sep;9(9):1471-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17576159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Neurobiol. 2013 Aug;48(1):190-204</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23436141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2004 Apr;70(4):399-401</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15041033</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2002 Feb 1;22(3):698-707</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11826099</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(12 ):e28502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22174823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci Res. 2010 Apr;88(5):1137-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19885829</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antioxid Redox Signal. 2012 Apr 1;16(7):649-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21967570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 2013 May 22;78(4):596-614</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23719160</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jul 23;279(30):31098-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15145938</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Fundam Clin Pharmacol. 2013 Dec;27(6):593-602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22943605</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurochem. 2009 Jul;110(1):220-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19457132</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Clin Nutr. 2007 Apr;85(4):929-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17413088</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2013 Oct 21;210(11):2415-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24101378</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr. 2012 Mar;142(3):592S-599S</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22279140</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2008 Oct;1778(10):2388-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18621018</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Alzheimers Dis. 2010 Dec 27;2011:603052</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21234417</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Pharm. 2010 Dec 6;7(6):2185-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20831192</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Death Dis. 2014 Feb 13;5:e1057</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24525733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nutr J. 2013 Nov 06;12(1):142</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24192015</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr Biochem. 2004 Nov;15(11):657-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15590269</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Rev Psychiatry. 2006 Apr;18(2):85-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16777663</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurochem. 1996 Apr;66(4):1582-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8627314</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Leukoc Biol. 2013 Apr;93(4):463-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23180828</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2009 Jun;1788(6):1398-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19376082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Sci. 2013 Sep 02;14(9):17897-925</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24002027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Gen Psychiatry. 1999 May;56(5):407-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10232294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 2005 Sep 1;47(5):709-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16129400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):322-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21587066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adipocyte. 2013;2(1):17-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23599907</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Med. 2013 Sep 17;11:205</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24229326</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Phys Lipids. 2003 Nov;126(1):1-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14580707</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Psychiatry. 1998 Mar 1;43(5):315-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9513745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Schizophr Bull. 2013 Nov;39(6):1174-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24072812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 1997;22(1-2):359-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8958163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2002 Mar 22;108(6):849-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11955437</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2010 Dec 1;30(48):16160-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21123562</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2005 Dec 30;1746(3):305-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16289370</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Neuropharmacol. 2014 Mar;12(2):168-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24669210</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Death Dis. 2013 Oct 03;4:e820</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24091663</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 2007 Jan 10;26(1):209-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17159908</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2001 Apr 6;276(14):10888-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11152679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Neurol. 2006 Oct;63(10):1402-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17030655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuro Endocrinol Lett. 2006 Oct;27(5):615-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17159817</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pharmacol Exp Ther. 2010 Mar;332(3):977-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19996298</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Nutr Soc. 2002 Aug;61(3):345-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12296294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Physiology (Bethesda). 2011 Feb;26(1):54-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21357903</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Affect Disord. 1996 Apr 26;38(1):35-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8735157</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1993 Dec 9;366(6455):562-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8255294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(5):e36330</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22662118</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2005 Aug 2;44(30):10164-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16042393</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Psychiatry. 2001 Mar;6(2):246-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11317232</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2014 Feb;1838(2):532-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23899502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr. 2011 Jun;141(6):1041-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21525263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Toxicol Mech Methods. 2013 Jun;23(5):368-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23343353</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biotechnol J. 2012 Jun;7(6):753-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22488962</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2007 Feb 1;178(3):1243-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17237368</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2008 Oct;1777(10):1249-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18721793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Phys Lipids. 2008 May;153(1):24-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18346461</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 2009 Oct 29;64(2):213-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19874789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Dev Immunol. 2013;2013:708659</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24174971</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2005 Nov 25;280(47):39380-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16195227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Chem Biol. 2010 Aug;6(8):610-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20601941</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cold Spring Harb Perspect Biol. 2011 Oct 01;3(10):a004697</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21628426</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Jun 23;9(6):e100519</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24956173</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Mol Genet. 2012 Dec 1;21(23):5131-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22926141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Psychiatr Res. 2012 Aug;46(8):1024-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22572570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Affect Disord. 1991 Feb;21(2):133-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1851504</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biochem Cell Biol. 2014 Apr;49:105-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24495877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Endocrinology. 2013 Nov;154(11):4293-304</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24008343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Nutr. 2009 May;101(9):1341-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19079834</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2012 Feb 16;11(2):140-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22341463</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Immunol. 2011;109:1-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21569911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Pharmacol Sci. 2013 Sep;34(9):489-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23968642</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Alzheimer Res. 2011 Mar;8(2):213-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21222605</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Mar 07;9(3):e89899</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24608521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Phytother Res. 2002 Mar;16 Suppl 1:S40-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11933138</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Behav Neurosci. 2014 Mar 27;8:104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24723866</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuroscience. 2014 Oct 10;278:354-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25168729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Neurosci. 2008 May;35(1):55-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18058074</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Struct Biol. 2002 Oct;12(5):587-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12464309</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Coll Nutr. 2009 Oct;28(5):525-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20439549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2004 Nov 15;173(10):6151-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15528352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Psychiatry Neurosci. 2011 Mar;36(2):78-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21118657</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2006 Apr 7;281(14):9337-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16464853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2009 Sep;1788(9):1731-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19433058</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2006 Mar 3;311(5765):1253-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16513974</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2005 Sep 1;39(5):584-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16085177</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Physiol. 2011 Dec 15;589(Pt 24):5909-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22174138</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Invest Dermatol. 2010 May;130(5):1457-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20054337</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuropharmacology. 2013 Jan;64:97-107</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22820274</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Breast Cancer Res. 2014 Feb 10;16(1):R19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24512624</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurochem. 2006 Mar;96(6):1531-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16464237</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 2009 Jul 13;186(1):147-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19596852</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 2006 Apr;20(6):770-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16469846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Subcell Biochem. 2004;37:425-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15376629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jul 23;279(30):31973-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15161911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Neuropsychopharmacol. 2014 Mar;17(3):383-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24300434</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Membr Biol. 2009 Jan;26(1):93-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19115146</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neuroimmunol. 1995 Feb;56(2):143-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7860710</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Lipid Res. 2013 Apr;54(4):923-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23349208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurochem. 2004 May;89(3):695-702</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15086526</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Pharmacol Sci. 2011 Sep;32(9):543-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21663979</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2014 Jun;95(Pt 6):1211-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24671751</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Clin Pract Neurol. 2009 Feb;5(2):82-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19194388</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Assoc Physicians India. 2005 Jul;53:623-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16190133</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oxid Med Cell Longev. 2012;2012:132146</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22701754</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Cell Dev Biol. 2007 Oct;18(5):608-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17890113</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(5):e37187</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22615937</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Psychiatry. 2012 Dec;17(12):1272-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21931319</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Sci. 2010 Nov 15;123(Pt 22):3831-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21048159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr. 1998 Dec;128(12):2512-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9868201</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3280-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14604995</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Exp Med Biol. 2012;729:29-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22411312</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Schizophr Res. 2009 Mar;108(1-3):3-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19128945</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oxid Med Cell Longev. 2012;2012:835970</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22655115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lipids Health Dis. 2009 Aug 10;8:33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19664246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2007 Sep 12;27(37):9901-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17855605</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Membr Biol. 2011 Mar;240(2):73-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21259001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 2004 Sep 2;43(5):633-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15339646</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Cell Biol. 2013;2013:797914</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24348565</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Alzheimers Dement. 2010 Nov;6(6):456-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20434961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Biol. 2006 Oct;26(19):7190-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16980621</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gerontol A Biol Sci Med Sci. 2005 Aug;60(8):970-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16127098</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2013 Jul 3;33(27):11169-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23825420</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurobiol Dis. 2010 Oct;40(1):207-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20685337</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO Rep. 2004 Nov;5(11):1053-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15520806</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thromb Haemost. 2003 Mar;1(3):566-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12871467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2002 Oct 25;277(43):40594-601</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12191995</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Psychiatr Res. 2012 Jun;46(6):819-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22520512</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr. 2009 Sep;139(9):1632-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19640970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):702-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21185346</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Sci. 2010 Dec 1;123(Pt 23):4007-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21084560</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurochem. 2008 May;105(3):714-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18194211</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Cell Neurosci. 2014 Jan 06;7:284</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24431989</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2013 Apr;13(4):257-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23524462</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2008 Mar 19;28(12):3042-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18354007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Neurobiol. 2013 Dec;48(3):883-903</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23761046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Neurol. 2005 Nov;58(5):730-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16240347</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2002 Mar 15;277(11):8755-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11748246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Neurol. 2012 Aug;69(8):1044-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22507886</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cardiovasc Res. 2010 May 1;86(2):219-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20202978</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Neurosci. 2002 Oct;3(10):791-802</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12360323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuromolecular Med. 2008;10(4):219-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18543124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Redox Biol. 2013;1:398-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25499576</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr. 1989 Dec;119(12 ):1880-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2576038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2010 Dec 1;49(11):1603-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20840865</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Sci. 2010 Feb 15;123(Pt 4):595-605</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20103534</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2002 Aug 9;277(32):28418-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12029091</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Affect Disord. 2013 Jul;149(1-3):23-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22898471</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>World J Biol Psychiatry. 2006;7(4):223-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17071542</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Coll Health. 2007 Sep-Oct;56(2):109-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17967756</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuro Endocrinol Lett. 2005 Dec;26(6):745-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16380690</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013;8(1):e53965</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23342049</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Res. 2014;2014:961863</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24741637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Redox Biol. 2013 Feb 12;1:94-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24024141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011 Jan 06;6(1):e15866</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21253588</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2007 Apr 18;27(16):4385-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17442823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Yi Chuan. 2012 Mar;34(3):289-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22425947</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2011 Aug 1;437(3):399-411</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21609323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2008 Nov 1;181(9):6236-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18941214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lipids. 2001 Sep;36(9):937-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11724466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Psychiatr Scand. 1993 Mar;87(3):160-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8465663</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2000 Jul 21;275(29):22037-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10801823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Lett. 2012 Feb 29;142(1-2):64-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22281390</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Commun Signal. 2009 Sep 04;7:21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19732448</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2012 Apr 6;287(15):11991-2005</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22315232</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2010 Apr 23;285(17 ):13022-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20178993</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2008 Feb 1;180(3):1398-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18209034</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Alzheimer Res. 2013 Feb;10(2):143-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22950913</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Cell Dev Biol. 2007;23:613-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17506699</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2013 Mar;1833(3):602-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23159491</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 May 07;9(5):e96905</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24805797</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 2003 Oct 9;40(2):361-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14556714</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 2007 Jan 29;176(3):249-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17242068</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Cell Neurosci. 2013 Oct 31;7:190</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24198758</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ Open. 2013 Apr 17;3(4):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23599375</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Neurosci. 2009 Nov;42(3):172-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19595769</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Res. 2008 Jan 15;68(2):553-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18199552</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Psychiatry. 2009 Jun;14(6):601-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18268500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Physiol. 2012 Apr 05;3:73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22493583</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biophys J. 2007 Dec 15;93(12):4225-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17766354</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Biosci (Schol Ed). 2011 Jan 01;3:298-330</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21196378</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Lipid Res. 2005 Sep;46(9):1904-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15930520</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prog Lipid Res. 2009 Sep;48(5):239-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19362576</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Oncol. 2012 Apr 20;30(12):1280-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22412148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Neurosci. 2007 Feb;8(2):128-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17195035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Cell Res. 2010 May 1;316(8):1351-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20211176</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dev Cell. 2011 Sep 13;21(3):445-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21885353</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Neurosci. 2009 Feb;12(2):119-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19122666</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Biol. 2013 Jul;11(7):e1001597</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23843742</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Med. 2012 Jun 29;10:66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22747645</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Chem Biol. 2013 Feb;17(1):27-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23332315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Neurol. 2003 Jul;60(7):940-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12873849</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2006 May;24(5):513-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16713970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr Biochem. 2013 Jan;24(1):104-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22819560</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neural Regen Res. 2014 Jan 1;9(1):92-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25206748</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuro Endocrinol Lett. 2007 Dec;28(6):861-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18063934</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biophys J. 2012 Jul 18;103(2):228-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22853900</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2004 Aug 11;24(32):7140-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15306647</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2013 Feb;1828(2):357-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22940500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mitochondrion. 2007 Jun;7 Suppl:S34-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17482527</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Membr Biol. 2010 Apr;27(2-3):123-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20334580</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2005 May;166(5):1283-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15855630</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Plant Sci. 2014 Oct 14;5:522</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25352853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Redox Rep. 2013;18(1):12-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23394493</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 2009 Mar;228(1):9-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19290918</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Clin Nutr. 2006 Jun;83(6 Suppl):1505S-1519S</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16841861</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2011 Dec;1808(12):2981-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21819967</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2009 Jan;1788(1):24-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19014904</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Cell Biol. 2012 Mar 19;13:6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22429589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Discov Today. 2014 Aug;19(8):1186-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24993159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oxid Med Cell Longev. 2013;2013:316523</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23983897</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Gastroenterol. 2007 Jan;23(1):48-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17133085</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Res Int. 2011;2011:245090</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22191032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2014 Jan 29;34(5):1903-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24478369</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Neurol Scand. 1990 Sep;82(3):209-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2270749</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2011 Feb 18;286(7):5175-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21118819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Biol. 2005 Aug;25(15):6722-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16024806</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Pharm Sin B. 2015 Jan;5(1):1-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26579419</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Life Sci. 2011 Jun;68(12):2003-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21207100</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Inflamm Res. 2000 Oct;49(10):497-505</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11089900</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2013 Mar 29;288(13):9112-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23396970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Schizophr Res. 2011 Jul;129(2-3):215-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21276713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurochem. 1999 Jun;72(6):2610-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10349873</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2014 Jun;1838(6):1451-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24189436</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2002 Feb 1;361(Pt 3):681-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11802799</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Cell Biol. 2012;2012:763283</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22253629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Alzheimers Dis. 2012;2012:459806</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22666620</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Biol. 2014 Nov 05;12:91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25371237</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1538-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18573585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Physiol. 2012 Jun 22;3:189</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22737128</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 2009 Jul 13;186(1):7-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19596846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2007 Jun 29;282(26):18661-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17488715</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Soc Trans. 2013 Feb 1;41(1):72-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23356261</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Schizophr Res. 2014 Sep;158(1-3):230-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24996507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Biol. 2014 Jul 15;12(7):e1001908</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25025157</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr. 2008 Sep;138(9):1807S-1812S</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18716191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Alzheimers Dis. 2014;38(1):111-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24077434</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuropsychopharmacology. 2012 Jan;37(1):309-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22157875</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Alzheimers Dis. 2010;19(2):489-502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20110596</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Soc Trans. 2013 Feb 1;41(1):84-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23356263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Lipid Res. 2008 Feb;49(2):340-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17991757</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2011 Aug 15;187(4):1626-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21742965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2010 Jan 1;327(5961):46-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20044567</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Neurosci. 2013 Nov;123(11):776-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23659338</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 2010 Dec 27;191(7):1229-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21187327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nutr Cancer. 2007;59(1):14-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17927497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychiatry Res. 1999 Mar 22;85(3):275-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10333380</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Cell Biol. 2012;2012:463756</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22956959</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Rep. 2014 Jul 10;8(1):217-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25001280</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Transl Psychiatry. 2011 Aug 16;1:e33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22832607</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr. 2003 Jun;133(6):1913-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12771339</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Chem Soc. 2006 Apr 26;128(16):5375-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16620109</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oxid Med Cell Longev. 2013;2013:709493</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23861993</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S14-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12142955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Alzheimer Res. 2011 Aug;8(5):479-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21605054</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Biochem Funct. 2009 Aug;27(6):338-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19569086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2013 Jan;88(1):43-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22515942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2885-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21282648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Immunol. 2012 Jun 12;3:155</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22701458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2014 Jun;1838(6):1467-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24440423</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2000 Jun 13;39(23):6918-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10841773</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 2011 Jul 14;71(1):131-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21745643</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Neurosci. 2005 Aug;22(3):617-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16101743</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2002 Oct 21;196(8):1025-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12391014</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Biol. 2002 Jan;22(2):400-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11756537</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nutr Biochem. 2004 Nov;15(11):700-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15590275</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prog Lipid Res. 2009 May-Jul;48(3-4):117-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19233228</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 May 7;279(19):19401-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14966136</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biologics. 2014 May 29;8:199-205</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24920882</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 2012 Feb;26(2):832-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22085642</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Leukoc Biol. 2013 May;93(5):771-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23444136</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurosci Lett. 2000 Apr 21;284(1-2):25-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10771153</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Physiol Nutr Metab. 2014 Apr;39(4):446-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24669986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22050-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21131568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1496-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17581830</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurosignals. 2006-2007;15(5):266-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17622793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 1999 Mar;22(3):497-509</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10197530</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Psychopharmacol. 2012 Apr;32(2):179-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22367656</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Neurobiol. 2014 Dec;50(3):1059-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24752591</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Cell Biol. 2001 Apr;3(4):368-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11283610</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Altern Med Rev. 2007 Dec;12(4):343-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18069903</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Neurosci. 2010 Mar;11(3):161-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20168314</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Pharmacol Sci. 2013 Mar;34(3):167-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23369637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Chem Soc. 2013 May 15;135(19):7082-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23631516</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2012 Apr 13;287(16):13465-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22375001</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Australie</li>
<li>Brésil</li>
<li>Royaume-Uni</li>
<li>Thaïlande</li>
</country>
<region><li>Victoria (État)</li>
</region>
<settlement><li>Melbourne</li>
</settlement>
<orgName><li>Université de Melbourne</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
</noRegion>
<name sortKey="Puri, Basant K" sort="Puri, Basant K" uniqKey="Puri B" first="Basant K" last="Puri">Basant K. Puri</name>
</country>
<country name="Australie"><noRegion><name sortKey="Walder, Ken" sort="Walder, Ken" uniqKey="Walder K" first="Ken" last="Walder">Ken Walder</name>
</noRegion>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</country>
<country name="Thaïlande"><noRegion><name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</noRegion>
</country>
<country name="Brésil"><noRegion><name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001644 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001644 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= PoplarV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:26310971 |texte= The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26310971" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a PoplarV1
This area was generated with Dilib version V0.6.37. |